Research
Hormonal
Pharmacological treatment with Semaglutide (2.4 mg) achieves clinically relevant weight loss (~16%) regardless of the intensity of concurrent lifestyle interventions.
Take Semaglutide 2.4 mg once weekly. While you should still try to eat slightly less and move more, do not expect these lifestyle changes to drive your weight loss. The medication does the heavy lifting by correcting your biology. Expect ~16% weight loss over 68 weeks.
StrongSupportsHIGH confidence
The patients in STEP 1 and STEP 3 lost similar amounts of weight (~16%) with semaglutide 2.4 mg despite very different intensity in behaviour programs
Why this rating
Based on cited RCTs (STEP 1, STEP 3, STEP TEEN).
Source
The Concept of Healthy Behaviours in Obesity May Have Unintended Consequences
Hilary C. Craig et al. · Nutrients · 2022
DOI 10.3390/nu15010012
narrative_reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →